FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934


For the month of January 2014

Commission File Number: 001-15152


SYNGENTA AG
(Translation of registrant’s name into English)

Schwarzwaldallee 215
4058 Basel
Switzerland
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
X
 
Form 40-F
 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
   
No
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
   
No
X

Indicate by check mark whether by furnishing the information contained in this Form, the Registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes
   
No
X

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A
 


 
 
 
 
 
 
Re:                      SYNGENTA AG
Disclosure:           Management announcement

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:

# # #

 
 

 

Syngenta International AG
 
Media inquiries:
 
Analyst/Investor contacts:
           
Media Office
   
Paul Barrett
   
Jennifer Gough
 
CH-4002 Basel
   
Switzerland
+41 61 323 2323
 
Switzerland
+41 61 323 5059
Switzerland
         
USA
+1 202 737 6521
Tel:
+41 61 323 23 23
           
Fax:
+41 61 323 24 24
 
 
   
Lars Oestergaard
 
       
 
 
Switzerland
+41 61 323 6793
www.syngenta.com
       
USA
+1 202 737 6520
 

 
Basel, Switzerland, January 8, 2014
 
Management announcement

Syngenta announced today that Robert Berendes, Head Business Development, will be leaving the company at the end of the first quarter to become co-owner and partner of a-connect, the global consulting firm specializing in strategy implementation, growth projects and change management. Robert joined Syngenta in 2002 from McKinsey & Company where he was a partner, and became a member of the Syngenta Executive Committee in 2007.

Mike Mack, Syngenta CEO said: “I should like to thank Robert for his outstanding contributions to Syngenta over the past 11 years, including most recently his ad interim leadership of R&D for the last 14 months. On behalf of the Executive Committee, I wish him every success in his new endeavor.”

Further information on a-connect and Robert Berendes is available here.

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com


Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

 
Syngenta – January 8, 2014 / Page 1 of 1
 
 
 

 
 
SIGNATURES

 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
   
SYNGENTA AG
 
       
       
Date:
January 8, 2014
 
By:
/s/ Sandra Bürli-Borner
 
       
Name:
Sandra Bürli-Borner
 
       
Title:
Deputy Head Shareholder Affairs
 
             
             
             
             
             
             
             
             
     
By:
 /s/ Brigitte Benz
 
       
Name:
Brigitte Benz
 
       
Title:
Head Shareholder Services & Group Administration